By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Eureka Genomics has netted $3.7 million in financing through a private round that included individuals and undisclosed angel investors.

The Hercules, Calif.-based company said today that it plans to use the funding to advance its studies of novel microorganisms linked to specific cancers and other diseases, and to boost sales and marketing for its high-throughput sequencing data and bioinformatics service businesses.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.